$UAMY

Marinelli Jon R purchased $93K of UAMY

Marinelli Jon R purchased 12,500 shares of UNITED STATES ANTIMONY CORP (UAMY) at $7.45 on 2026-06-15.

Original reporting
SEC EDGAR · Marinelli Jon R
Published Jun 17, 2026, 5:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 17, 2026, 5:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$UAMY
Bullish
low confidence
Mentioned
$UAMY
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UAMYBullishLow
01

Why it matters

The newest fact is the director’s open-market purchase (12,500 shares at $7.45) disclosed via EDGAR on 2026-06-17.

02

Market read

Traders may note mild sentiment support from insider buying, but there’s no fundamental update to underwrite a directional trade.

03

What to watch

The article doesn’t state whether the purchase was part of a broader pattern, whether other insiders bought/sold, or whether the company has upcoming catalysts that would make the buy more informative.

Relevance 4/10Novelty 6/10Timing: SEC Form 4 filed 2026-06-17 (covering 2026-06-15 purchase)

Background

The article is an SEC Form 4 insider transaction disclosure for United States Antimony Corp (UAMY).

Company-level read

Ticker impact

$UAMYBullishLow confidence
Context

Marinelli Jon R (director) filed an open-market purchase of 12,500 shares at $7.45 on 2026-06-15, totaling $93,125.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures.

Evidence & confidence

The filing is a Form 4 insider purchase with relatively small dollar value and no accompanying operational/regulatory/financial change disclosed.

Market effects

No sector read-across; this is a single-company insider transaction with no stated business development.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine or driven by personal liquidity/compensation mechanics; without a 10b5-1 plan or additional context, signal strength is weak.

Key entities

  • United States Antimony Corp

    Subject of the Form 4 insider transaction; director Marinelli Jon R purchased 12,500 shares at $7.45.

  • Marinelli Jon R

    Director who reported an open-market purchase totaling $93,125; no pre-arranged 10b5-1 plan indicated.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles